Skip to main content
Caplight Logo









Genomic Life

Genomic Life

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://genomiclife.com/

Last Round

Early Funding

May 6, 2024

Total Funding Raised

$10M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Genomic Life is a healthcare and biotechnology company that provides a genetics-based healthcare navigation program offering DNA screenings, personalized health guidance, and cancer navigation services for employees and individuals.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Biotechnology, Patient Engagement, InsurTech

Business Model

B2B2C

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

genomic benefit programgenetic testinggenetic counselingclinical navigationprecision medicinecancer genomicsemployee health benefitsPEPMper-employee-per-monthdigital healthhealth navigationemployer-sponsored healthcarehereditary risk assessmentB2B2C healthcaregenomics concierge

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Genomic Life Comparables

Compare Genomic Life with similar companies based on industry and business-model similarity.

Genomic Life comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
InformedDNA
79%
Genome Medical
78%
Color Health, Inc.
76%

Genomic Life Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingMay 6, 2024
Series BFeb 1, 2021

Genomic Life Investors

Notable investors and investment history

Genomic Life investors
InvestorRounds
Casdin CapitalSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors increased 119% MoM.

  • May 8, 2025

    Bupa now offers Health Insights test in the UK.

Genomic Life Filings

Explore SEC and related filing metadata, where available.

Genomic Life filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Genomic Life's valuation, stock price, and market status.

Is Genomic Life a public or private company?

Genomic Life is a private company.

What is the current stock price of Genomic Life?

Genomic Life is a private company with no public stock price. No recent secondary market data is available.

How much is Genomic Life worth (valuation)?

Valuation information for Genomic Life is not publicly available.

Can I buy Genomic Life stock?

Genomic Life shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Genomic Life's last funding round?

Genomic Life's most recent funding round was Series C on May 6, 2024.

Who are the main investors in Genomic Life?

Key investors in Genomic Life include Casdin Capital.

Will Genomic Life IPO soon?

No public IPO plans have been announced for Genomic Life.

How can I track Genomic Life secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Genomic Life's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Diego, California
Employee Range43
Year Founded2017
Last FundingMay 6, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?